Intrexon | XON - Ebit





Ebit Veränderung Datum
Agenus USD 14.4M 19.26M 2025-12
Alaunos Therapeutics USD -1.19M 148K 2025-09
Amgen USD 3.83B 130M 2026-03
Anika Therapeutics USD 646K 3.88M 2025-12
Arrowhead Research USD -141.26M 182.07M 2026-03
AstraZeneca USD 7.11B 4.14B 2026-03
Bristol-Myers Squibb USD 3.56B 90M 2026-03
Gilead Sciences USD 2.68B 284M 2026-03
GlaxoSmithKline GBP 2.29B 856M 2026-03
Heron Therapeutics USD 38K 3.83M 2025-12
Incyte USD 344.17M 39.71M 2026-03
Intrexon USD -26.3M 2.91M 2024-06
Karyopharm Therapeutics USD -17.84M 8.44M 2025-12
Ligand Pharmaceuticals USD 60.33M 1.76M 2026-03
MacroGenics USD -12.1M 32.26M 2025-12
MannKind USD -76.99M 7.75M 2026-03
Merck USD -1.88B 8.12B 2026-03
Novartis USD 4.18B 118M 2026-03
Rigel Pharmaceuticals USD 447K 1.52M 2024-06
Roche Holding CHF 9.56B 2.1B 2025-12
Thermo Fisher Scientific USD 1.91B 389M 2026-03
Veracyte USD 19.08M 5.55M 2026-03
Xencor USD -77.86M 24.23M 2026-03